First Time Loading...

Japan Animal Referral Medical Center Co Ltd
TSE:6039

Watchlist Manager
Japan Animal Referral Medical Center Co Ltd Logo
Japan Animal Referral Medical Center Co Ltd
TSE:6039
Watchlist
Price: 1 976 JPY -0.2% Market Closed
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

735m
-9%
Operating Cash Flow
Growth Rates:
1 Year
-2%
3 Years
+28%
5 Years
+50%
7 Years
+104%
10 Years
-
-1.4B
-80%
Investing Cash Flow
Growth Rates:
1 Year
+4%
3 Years
-1 280%
5 Years
-139%
7 Years
-77%
10 Years
-
1.2B
+48%
Financing Cash Flow
Growth Rates:
1 Year
+53%
3 Years
-
5 Years
+279%
7 Years
+154%
10 Years
-

Cash Flow Statement
Japan Animal Referral Medical Center Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: JPY
Sep-2016 Mar-2017 Sep-2017 Mar-2018 Sep-2018 Mar-2019 Sep-2019 Mar-2020 Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023
Operating Cash Flow
Net Income
219
268
298
254
295
391
433
452
425
412
401
424
534
534
392
Depreciation & Amortization
214
202
173
177
212
224
217
218
228
220
214
241
332
412
422
Other Non-Cash Items
31
66
58
8
22
45
36
10
23
31
23
34
34
94
122
Cash Taxes Paid
52
70
40
32
49
60
87
102
133
152
112
107
129
155
216
Cash Interest Paid
40
38
31
21
18
17
16
16
14
13
13
13
15
17
18
Change in Working Capital
(103)
(107)
(15)
(94)
(40)
81
(124)
(141)
(102)
(159)
(116)
(141)
(148)
(228)
(201)
Cash from Operating Activities
360
N/A
429
+19%
514
+20%
344
-33%
489
+42%
741
+52%
562
-24%
538
-4%
573
+7%
504
-12%
521
+3%
558
+7%
753
+35%
811
+8%
735
-9%
Investing Cash Flow
Capital Expenditures
(789)
(1 112)
(600)
(789)
(583)
(101)
(101)
(88)
(96)
(66)
(118)
(602)
(658)
(742)
(1 378)
Other Items
(11)
(9)
(20)
(9)
(9)
(7)
(6)
(6)
(7)
(4)
(19)
(824)
(820)
(42)
(36)
Cash from Investing Activities
(800)
N/A
(1 121)
-40%
(620)
+45%
(798)
-29%
(592)
+26%
(108)
+82%
(108)
+1%
(93)
+13%
(102)
-10%
(70)
+32%
(137)
-96%
(1 426)
-943%
(1 479)
-4%
(784)
+47%
(1 414)
-80%
Financing Cash Flow
Net Issuance of Common Stock
15
3
9
33
28
6
6
(8)
(155)
(137)
7
(113)
(113)
776
778
Net Issuance of Debt
466
699
161
452
294
(277)
(428)
(430)
(328)
(330)
(436)
845
919
48
441
Other
(2)
(2)
0
0
(2)
(3)
(2)
(8)
(8)
(2)
(3)
(10)
(11)
(3)
(2)
Cash from Financing Activities
479
N/A
700
+46%
168
-76%
485
+189%
321
-34%
(273)
N/A
(423)
-55%
(446)
-5%
(491)
-10%
(469)
+4%
(433)
+8%
722
N/A
795
+10%
821
+3%
1 216
+48%
Change in Cash
Net Change in Cash
38
N/A
8
-79%
63
+695%
32
-49%
217
+579%
360
+66%
32
-91%
(1)
N/A
(20)
-1 817%
(35)
-69%
(48)
-39%
(146)
-204%
69
N/A
847
+1 136%
538
-37%
Free Cash Flow
Free Cash Flow
(429)
N/A
(683)
-59%
(86)
+87%
(444)
-419%
(94)
+79%
640
N/A
461
-28%
450
-2%
477
+6%
439
-8%
403
-8%
(44)
N/A
94
N/A
69
-27%
(643)
N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.